InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the full record of transactions filed by Carter Martha J., Directeur Réglementaire. Officer active across 1 companies, notably Albireo Pharma, INC.. Cumulatively, 5 filings have been published. Total volume traded: €21k. The latest transaction was disclosed on 22 April 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
€3,130103 shares@ €30.386914.6% of flow
Common Stock
SEC:0001209191-22-025529:0·
€9,144423 shares@ €21.6164100.0% of flow
Common Stock
SEC:0001209191-22-004799·
€9,144423 shares@ €21.616442.7% of flow
Common Stock
SEC:0001209191-22-004799:0·
010,800 shares0
Common Stock
SEC:0001209191-22-004067:0·
010,800 shares0
Common Stock
SEC:0001209191-22-004067·
5 of 5 declarations
About Carter Martha J.
Martha J. Carter is the Chief Regulatory Officer at ALBIREO PHARMA, INC. She is responsible for overseeing regulatory and compliance matters within the company. With a strong background in the pharmaceutical sector, Martha plays a key role in ensuring that Albireo's products meet current standards and regulations. Her commitment to compliance is essential in maintaining the company's reputation.
